27 April 1987
INTERIM COMMERCIAL ITEM DESCRIPTION
POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES, USP
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Materiel, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Shall be Potassium Chloride Extended-Release Capsules, USP.
Shall be in accordance with the requirements of the USP.
All ingredients shall be of pharmaceutical grade,
For Strength 1, shall contain 600 mg of Potassium Chloride, equivalent to 8 mEq of Potassium per capsule, within the applicable assay limits.
For Strength 2, shall contain 750 mg of Potassium Chloride, equivalent to 10 mEq of Potassium per capsule, within the applicable assay limits.
The Capsules must be considered by the FDA to be therapeutically equivalent with Potassium Chloride Extended-Release Capsules by A.H. Robins at the same dosage and administration schedule.
Workmanship. The capsules shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Bottle (BT). One bottle containing 500 capsules, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business